Design Therapeutics (NASDAQ:DSGN - Get Free Report) is expected to be releasing its earnings data before the market opens on Tuesday, March 18th. Analysts expect Design Therapeutics to post earnings of ($0.27) per share for the quarter.
Design Therapeutics (NASDAQ:DSGN - Get Free Report) last issued its earnings results on Monday, March 10th. The company reported ($0.24) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.28) by $0.04. On average, analysts expect Design Therapeutics to post $-1 EPS for the current fiscal year and $-1 EPS for the next fiscal year.
Design Therapeutics Trading Down 0.2 %
DSGN stock traded down $0.01 on Friday, hitting $4.71. The company had a trading volume of 97,845 shares, compared to its average volume of 177,425. Design Therapeutics has a 12-month low of $2.45 and a 12-month high of $7.77. The stock's 50-day simple moving average is $4.80 and its 200 day simple moving average is $5.35. The stock has a market cap of $266.68 million, a price-to-earnings ratio of -5.54 and a beta of 1.77.
About Design Therapeutics
(
Get Free Report)
Design Therapeutics, Inc a biopharmaceutical company, researches, designs, develops, and commercializes small molecule therapeutic drugs for the treatment of genetic diseases in the United States. The company utilizes its GeneTAC platform to design and develop therapeutic candidates for inherited diseases caused by nucleotide repeat expansion.
Read More
Before you consider Design Therapeutics, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Design Therapeutics wasn't on the list.
While Design Therapeutics currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
